| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBMT.2011.05.001 |
| P698 | PubMed publication ID | 21620989 |
| P50 | author | Aldona Dlugosz | Q38330748 |
| Annika Wernerson | Q41139346 | ||
| Richard Olsson | Q42810536 | ||
| Maciej Machaczka | Q43278759 | ||
| Jonas Mattsson | Q44779136 | ||
| Göran Dahllöf | Q50532709 | ||
| Karl-Johan Malmberg | Q56839940 | ||
| Helen Karlsson | Q60490881 | ||
| Jens Gertow | Q62666370 | ||
| Sofia Berglund | Q62666373 | ||
| Mats Remberger | Q62670226 | ||
| Lena Klingspor | Q89154054 | ||
| Olle Ringden | Q89625226 | ||
| Zuzana Hassan | Q114449229 | ||
| Brigitta Omazic | Q114449230 | ||
| P2093 | author name string | Ann-Charlotte Wikström | |
| Jacek Winiarski | |||
| Hanns-Ulrich Marschall | |||
| Hans Hägglund | |||
| Agneta Wikman | |||
| Marie Schaffer | |||
| Per Ljungman | |||
| Katarina Le Blanc | |||
| Moustapha Hassan | |||
| Britt Gustafsson | |||
| Malin Ackefors | |||
| Attila Szakos | |||
| Ola Blennow | |||
| Britt-Marie Svahn | |||
| Mehmet Uzunel | |||
| Petter Svenberg | |||
| Gunilla Kumlien | |||
| Dan Hauzenberger | |||
| Lisa Swartling | |||
| Michael Uhlin | |||
| Darius Sairafi | |||
| Karin Garming-Legert | |||
| Emma Watz | |||
| P433 | issue | 11 | |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 1688-1697 | |
| P577 | publication date | 2011-05-11 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study | |
| P478 | volume | 17 |
| Q33573529 | A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation |
| Q54052781 | Active acute leukaemia: should transplant be offered to all patients? |
| Q50079881 | Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation |
| Q34413233 | Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors |
| Q64231936 | An Explorative Study of Qualities in Interactive Processes with Children and Their Parents in Music Therapy during and after Pediatric Hematopoietic Stem Cell Transplantation |
| Q40122841 | Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation |
| Q90463763 | Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation |
| Q39202357 | Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis |
| Q53536804 | Bone marrow aspiration technique has deteriorated in recent years. |
| Q50989345 | Cataract after allogeneic hematopoietic stem cell transplantation in childhood. |
| Q58776904 | Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
| Q48119892 | Danaparoid reduces transplant-related mortality in stem cell transplantation for children |
| Q38867148 | Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation. |
| Q35285004 | Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy |
| Q52984834 | Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands. |
| Q43988469 | General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care |
| Q40373921 | HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT. |
| Q89767646 | Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients |
| Q47425400 | Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease |
| Q43486658 | Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital |
| Q41520774 | Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest? |
| Q31068753 | Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells. |
| Q48344365 | Improved outcomes with allogeneic hematopoietic cell transplantation |
| Q92492472 | Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant |
| Q35078368 | Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research |
| Q64249488 | Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion |
| Q38513113 | Kidney diseases associated with haematological cancers |
| Q45243246 | Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD). |
| Q36010605 | Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant? |
| Q48295098 | Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation |
| Q91945665 | MBI-LCBI and CLABSI: more than scrubbing the line |
| Q45866879 | Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. |
| Q30387478 | Music therapy can lower the heart rates of severely sick children. |
| Q90458684 | Music therapy supported the health-related quality of life for children undergoing haematopoietic stem cell transplants |
| Q60956739 | Network Pharmacology-Guided Development of a Novel Integrative Regimen to Prevent Acute Graft-vs.-Host Disease |
| Q47189367 | Occupational status among adult survivors following allogeneic stem cell transplantation in childhood. |
| Q52881816 | Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index. |
| Q64122847 | Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades |
| Q38751585 | Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation. |
| Q52658261 | Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease. |
| Q49709281 | Prognostic Factors for Mortality among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation |
| Q41046376 | Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients |
| Q41742166 | Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation |
| Q47860871 | Rates and predictors of psychotherapy utilization after psychosocial evaluation for stem cell transplant |
| Q43454910 | Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia |
| Q37552052 | Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation |
| Q36951734 | Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors |
| Q48144263 | Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie C |
| Q44059940 | Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies |
| Q40288619 | Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. |
| Q39095853 | Stem cell transplantation during cancer |
| Q47955823 | Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients. |
| Q41879404 | To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision |
| Q38124392 | Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years |
| Q64942557 | Visual evoked potentials after hematopoietic allogeneic stem cell transplantation in childhood. |
| Q48191465 | What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? |
Search more.